Hypera S.A. Hypera S.A.

Hypera S.A.

HYPE3

Kedudukan dalam Saham #4241
Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical... Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical enterprise. The company's comprehensive product line encompasses a wide array of prescription medications, featuring established brands such as Adacne, Celestamine, Cizax, Diprosone, and Emprol XR, among many others. Beyond prescription drugs, Hypera offers specialized dermo-cosmetics through its Mantecorp Skincare brand. Its consumer health division markets popular remedies like Apracur, Benegrip, Engov, and Estomazil. Additionally, Hypera provides nutritional and vitamin supplements, including well-known names such as Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal. The company also maintains a significant presence in the generic and similar medicines market, offering products under the Neo Química brand and common formulations like Ibuprofen, Paracetamol, and Omeprazole. The organization officially became Hypera S.A. in February 2018, having previously operated as Hypermarcas S.A.
Harga Saham
$5.32
Modal Pasaran
$3.74B
Perubahan (1 hari)
2.01%
Perubahan (1 tahun)
25.08%
Negara
BR
Perdagangan Hypera S.A. (HYPE3)

Kategori

Healthcare
Sejarah harga saham bagi Hypera S.A. (HYPE3)
Harga penutupan tertinggi: $5.03 pada 2026-10-01

Harga penutupan terendah: $4.81 pada 2008-04-01
Sejarah harga saham Hypera S.A. dari 2008 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -0.71%
2025 45.17%
2024 -58.10%
2023 -12.37%
2022 62.46%
2021 -21.43%
2020 -22.43%
2019 1.82%
2018 -25.66%
2017 46.20%
2016 28.75%
2015 -6.93%
2014 -19.33%
2013 0.07%
2012 62.59%
2011 -67.38%
2010 28.81%
2009 327.96%
2008 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$171.67 -
DE
$161.15 21.02%
DE
$41.46 47.41%
JP
$212.49 23.19%
CH
$19.19 -0.09%
IN